Related Experiment Video
Updated: Aug 29, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Sarcomas of the breast
1Hedle Atkins Breast Unit, Guy's Hospital, London, UK.
Abstract:
Breast sarcomas are rare lesions that can be derived from any of the mammary stromal cells. A phyllodes tumour may resemble a rapidly growing fibroadenoma but in an older age group. Behaviour ranges from benign to frankly malignant and cannot always be predicted from the histological appearance. For all the sarcomas spread is haematogenous rather than lymphatic and treatment is based on wide surgical clearance without axillary surgery. Angiosarcoma is a rare consequence of skin irradiation as part of breast conservation therapy. Fibrosarcomas have a tendency to relapse locally unless wide surgical margins have been achieved. Radiotherapy is not of value but chemotherapy can be used to palliate women with metastatic disease.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
